Skip to content

Search Results

No Matching Results

    Recently Viewed

      Listening...

      HomeLatest newsWhat you need to know about Johnson & Johnson’s 2020 fourth-quarter and full-year earnings report
      lede-What You Need to Know About Johnson & Johnson's 2020 Fourth-Quarter and Full-Year Earnings Report.png

      What you need to know about Johnson & Johnson’s 2020 fourth-quarter and full-year earnings report

      Check out this infographic breakdown of the company’s fourth-quarter and annual performance, with highlights from its consumer, pharmaceutical and medical devices businesses.

      Share Article
      share to
      fourth-quarter-and-full-year-earnings-banner-0122.png

      Today, Johnson & Johnson shared its 2020 fourth-quarter and full-year earnings report.

      Since its founding in 1886, the company has grown to become one of the world’s largest and most broad-based healthcare companies, with approximately 135,000 employees across the globe working every day to help change the trajectory of health for humanity.

      “We achieved notable financial and operational performance in 2020 despite the many challenges and uncertainties presented by the global pandemic,” says Joe Wolk, Executive Vice President, Chief Financial Officer, Johnson & Johnson. “This is a true testament to the strength and resilience of our broad-based business and the dedication of our global Johnson & Johnson colleagues to deliver on our commitments to patients and customers. Our unbridled focus and ability enabled us to stay the course across our three business segments to advance breakthrough innovation. Simultaneously, we advanced our COVID-19 vaccine candidate and look forward to sharing Phase 3 data soon. Johnson & Johnson is poised for future strong performance as we work to continue delivering better health solutions for everyone, everywhere.”

      For more details about the company’s 2020 fourth-quarter and full-year results, and to read a message from Chairman and Chief Executive Officer Alex Gorsky, here’s an infographic packed with key stats.


      Johnson & Johnson 2020 4th Quarter and Full Year Earnings infographic

      Johnson & Johnson’s 2020 Earnings

      Read the earnings press release, which includes fourth-quarter and full-year financial data for 2020.

      Want to see more company earnings information? Find Johnson & Johnson’s past quarterly and full-year results here.


      More from Johnson & Johnson

      Meet a nurse who leads clinical trials to find innovative cancer therapies

      Melissa Martinez is a clinical scientist within Johnson & Johnson’s Interventional Oncology R&D group. Not only is she helping to develop lifesaving treatments, she’s redefining what it means to pursue a career in nursing.

      What’s the difference between IBS and IBD?

      These GI conditions sound similar, and they also share some symptoms. But IBS and IBD are distinct disorders—especially when it comes to treatment and the risk of complications.

      What is IL-23?

      This pro-inflammatory protein is the target of potential Johnson & Johnson medications that could help treat autoimmune conditions such as psoriasis, inflammatory bowel disease and rheumatoid arthritis.
      You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.